Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

vents was 9.3% in the Albuferon 900 Q2w treatment group, vs. 6.1% in the Pegasys group.

"The 900-mcg Albuferon dose has the potential to offer patients an attractive therapeutic option, requiring half as many injections as Pegasys, with more favorable quality of life effects and favorable sustained virologic response data," said David C. Stump, M.D., Executive Vice President, Research and Development, HGS.

    Albuferon 1200-mcg Every Two Weeks (Albuferon 1200 Q2w)


    -- ITT analysis shows that 55.5% of patients in the Albuferon 1200 Q2w

       treatment group achieved SVR, vs. 57.9% for Pegasys administered every

       week.

    -- In heavier patients (>75 kg) who were treatment-adherent, 67.9% of

       those in the Albuferon 1200 Q2w treatment group achieved SVR, versus

       53.3% for Pegasys every week.

    -- Among all treatment-adherent patients in the Albuferon 1200 Q2w

       treatment group, 70.6% achieved SVR, versus 66.7% for Pegasys.

    -- ITT analysis shows that the Albuferon 1200 Q2w treatment group

       exhibited a robust early antiviral response (reduction in hepatitis C

       RNA viral load to below the level of quantitation):  74.5% for

       Albuferon 1200 Q2w at Week 12, vs. 65.8% for Pegasys.  The Albuferon

       1200 Q2w treatment group also had the most rapid time to HCV RNA

       negativity.

    -- The rate of discontinuations due to adverse events was 18.2% in the

       Albuferon 1200 Q2w treatment group, vs. 6.1% in the Pegasys group.

       Adverse events observed were those typically expected with interferon

       therapy.  Dose reductions were attempted in only 30.0% of Albuferon

       subjects prior to discontinuation, versus 42.9% for Pegasys.

"In the Albuferon Phase 3 trials, we will strongly encourage titration of dose where necessary to ensure tolerability, reduce the rate of discontinuations, and maximize the therapeutic benefit of the robust early antiviral
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:9/19/2014)... Sept. 19, 2014  Over 200 runners participated in ... Benefit the Radiation Oncology Institute (ROI), hosted by Radiation ... Gate Park in San Francisco.  "Donations ... CEO of Radiation Business Solutions, "but at this ... over $70,000 for the ROI this year. This surpasses ...
(Date:9/19/2014)... 19, 2014  PCI is pleased to announce ... is a leading provider of Clinical Trial Services ... Wales in the ... expands PCI,s presence in the UK/EU to support ... packaging, storage and distribution capacity, as well as ...
(Date:9/18/2014)... 18, 2014  LABSCO, the leading specialty ... products to hospitals, physician office laboratories and ... distributorship agreement with Sysmex America.  This agreement ... including the Sysmex XS-1000 i ™, Sysmex ... XN-Series Automated Hematology Analyzers. The ...
Breaking Medicine Technology:Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3
... Terumo Heart, Inc. announced,today that it ... the European,Association of Cardio-Thoracic Surgeons (EACTS) meeting ... ) (Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO ) ... Trial results for the DuraHeart(TM),Left Ventricular Assist ...
... analysis reported,at the American Society for Bone and ... decreased clinical fracture risk by 50% over,three years ... women with,osteoporosis who had suffered a previous hip ... evaluated the combined incidence,of vertebral and nonvertebral clinical ...
Cached Medicine Technology:Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results 2Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture 2Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture 3Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture 4
(Date:9/19/2014)... September 19, 2014 BCC Research reveals ... AND GLOBAL MARKETS , the global market for human ... billion by 2018, with a five-year compound annual growth ... is growing at a steady 3.8% CAGR. , Given ... lower sales, coupled with the incidence of increasing mortality ...
(Date:9/19/2014)... 2014 Singulair, developed by Merck, is ... leukotriene D4 (LTD4). LTD4 belongs to the family of ... cells, including mast cells and eosinophils, and which bind ... determined that there are higher concentrations of Cys-LTs in ... individuals. The production of CysLTs is increased in asthmatics, ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Follow ... part of the medical imaging market, are engineered to ... developments over the past three decades have expanded the ... barium and iodine based agents used for over half ... and radiopharmaceuticals, imaging agents have witnessed sea changes, revolutionizing ...
(Date:9/19/2014)... 2014 Recent financial data reveled ... increased their sales by 7% in the last quarter ... industry can be used as a bellwether to determine ... This data has been proven to show trends with ... transportation. Other non-trucking data is largely influenced by international ...
(Date:9/19/2014)... September 19, 2014 TMG Health, ... solutions for Health Plans in the Medicare Advantage, ... sponsor a Networking Breakfast Session with featured speaker ... Advisory Practice at Pricewaterhouse Coopers, from 7:45-8:30 a.m. ... 2014 National Conference on Medicare in Washington, D.C. ...
Breaking Medicine News(10 mins):Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 4Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 2Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 3Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 4Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 2Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 3Health News:TMG Health To Sponsor Pricewaterhouse Coopers Speaker at AHIP’s National Conference on Medicare 2Health News:TMG Health To Sponsor Pricewaterhouse Coopers Speaker at AHIP’s National Conference on Medicare 3
... Food and Drug Administration (FDA) is asking for comment on ... industry, developed in response to section 1005 of the Food ... RFR is scheduled for implementation on September 8, 2009, and ... Only infant formula is exempt from the RFR requirements. , ...
... YOKNEAM, Israel and PLYMOUTH MEETING, Pa., June 16 On ... for the State of Delaware, granted Galil Medical Ltd.,s motion ... Inc., arising out of Endocare,s alleged breach of the Galil/Endocare ... argument, and ordered that a two-day trial would be held ...
... Point-of-Care Patient Payment Collection Software powered by mPay Gateway ... Systems, Inc., a leading provider of connected healthcare technology ... of NetPay, a web-based application that integrates with NetPracticePM(TM) ... at the point of service when patients are still ...
... - Awards Recognize Outstanding Design Innovation in Casegoods, Seating, Tables ... Steelcase Inc. (NYSE: SCS ), a global ... companies won five Best of NeoCon awards, including two Gold ... and a leading manufacturer of furniture for healthcare environments, won ...
... while Preserving the Designer,s Layout , , TUCSON, Ariz., ... in reading technology, today announced the launch of its ReadSmart ... the iTunes App Store(TM). The apps, available at the iTunes ... books for download that retain the look and design of ...
... UPTON, NY Researchers at the U.S. Department of Energy,s ... x-ray imaging technique that could be developed into a method ... been used to look at tumors in breast tissue and ... is the first to test its ability to visualize a ...
Cached Medicine News:Health News:Reportable Food Registry Draft Guidance Published for Comment by FDA 2Health News:Delaware Chancery Court Grants Galil Medical Ltd.'s Motion for Expedited Proceeding in Suit Against Endocare 2Health News:Noteworthy Medical Systems Introduces NetPay(TM) 2Health News:Steelcase Inc. Receives Five Best of NeoCon Awards and Best Overall Showroom for Nurture at NeoCon 2009 2Health News:Steelcase Inc. Receives Five Best of NeoCon Awards and Best Overall Showroom for Nurture at NeoCon 2009 3Health News:Language Technologies Introduces ReadSmart Edition Apps(TM) for the iPhone(TM) and iPod(R) Touch; Unique Apps Improve Ergonomics of Reading while Retaining Look and Design of Print Books 2Health News:Language Technologies Introduces ReadSmart Edition Apps(TM) for the iPhone(TM) and iPod(R) Touch; Unique Apps Improve Ergonomics of Reading while Retaining Look and Design of Print Books 3Health News:Language Technologies Introduces ReadSmart Edition Apps(TM) for the iPhone(TM) and iPod(R) Touch; Unique Apps Improve Ergonomics of Reading while Retaining Look and Design of Print Books 4Health News:X-rays for early Alzheimer's disease detection 2Health News:X-rays for early Alzheimer's disease detection 3
As part of a complete all-in-one system, Sentry LabelBand securely seals inexpensive paper labels inside a clear, adhesive shield. LabelBand provides easy and accurate bar code scanning and protectio...
... PDCs computer-generated Thermal Printing Wristbands and ... direct thermal and thermal transfer printers. ... activate a heat-sensitive thermal coating under ... printers use heat to transfer highly ...
... for use in settings, such ... where you may need a ... easy to apply but very ... width is increased to 1 ...
A unique and cost effective one-piece adhesive closure patient bracelet with a tamper- resistant feature that has been designed for patient comfort, caregiver productivity, and long term durability....
Medicine Products: